LIPOCINE INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
LIPOCINE INC. (LPCN) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $833.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2022-05-09
- 2022-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $833.00K.
- 2021-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $833.00K.
- 2021-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.67M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2022-03-31 | $833.00K 10-Q · filed 2022-05-09 |
| 2021-09-30 | $833.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.67M 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |